|
1) Catanese KA, Goldstein DJ, Williams DL, et al. Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg. 1996; 62: 646-52. discussion 653
|
|
|
|
2) Atsumi K, Fujimasa I, Imachi K, et al. How can the total artificial heart(TAH)patient be mobile and enjoy his life with an air driven system？ Trans Am Soc Artif Intern Organs. 1984; 30: 86-91
|
|
|
|
|
|
3) 古田昭一, 他. 補助人工心臓の臨床. 人工臓器. 1981; 10: 657-60
|
|
|
|
|
|
4) Joyce LD, DeVries WC, Hastings WL, et al. Response of the human body to the first permanent implant of the Jarvik-7 Total Artificial Heart. Trans Am Soc Artif Intern Organs. 1983; 29: 81-7
|
|
|
|
|
|
5) Dowling RD, Gray LA Jr, Etoch SW, et al. Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg. 2004; 127: 131-41
|
|
|
|
|
|
6) Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001; 345: 1435-43
|
|
|
|
|
|
7) Long JM, et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: Improved outcomes since the REMATCH Study. Congest Heart Fail. 2005; 11: 133-8
|
|
|
|
|
|
8) Slaughter MS, Rogers JG, Milano CA, et al. HeartMate II Investigators; Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009; 361: 2241-51
|
|
|
|
|
|
9) Brinkman WT, Rosenthal JE, Eichhorn E, et al. Role of a percutaneous ventricular assist device in decision making for a cardiac transplant program. Ann Thorac Surg. 2009; 88: 1462-6
|
|
|
|
|
|
10) 李 啓充. 神の委員会(14) Destination therapyに対する｢しばり｣. (連載)続 アメリカ医療の光と影. 週間医学界新聞. 第2572号(2004年2月16日)
|
|
|
|
|
|
11) 許 俊鋭. 循環器診療の質の向上とそれを阻害するもの 埋め込み型LVASの臨床導入: ノバコア保険償還の経緯と今後の課題. Cardiovascular Med-Surg. 2005; 17: 87-91
|
|
|
|
|
|
12) Hernandez AF, Shea AM, Milano CA, et al. Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA. 2008; 300: 2398-406
|
|
|
|
|
|
13) Lietz K, Long JW, Kfoury AG, et al. Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry. 1998 to 2005. Circ Heart Fail. 2009; 2: 3-10
|
|
|
|
|
|
14) 許 俊鋭, 小野 稔, 西村 隆, 他. 特集｢移植の医療経済｣各臓器移植分野における医療経済的な整理. 心臓移植の医療経済. 移植. 2009; 44: 10-1
|
|
|
|
|
15) 津久井宏行, 山嵜健二. 脳死移植と補助人工心臓-その相互補完関係-. 移植. 2009; 44(特別号): S214-6
|
|
|
|
|
|
16) Saito S, Matsumiya G, Sakaguchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J. 2010; 74: 624-5
|
|
|
|
|
17) Sasaoka T, Kato TS, Komamura K, et al. Improved long-term performance of pulsatile extracorporeal left ventricular assist device. J Cardiol. 2010; 56: 220-8
|
|
|
|
|